{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:21:26Z","timestamp":1759335686950},"reference-count":26,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1986,2,1]]},"DOI":"10.1136\/hrt.55.2.176","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:46:00Z","timestamp":1190151960000},"page":"176-180","source":"Crossref","is-referenced-by-count":11,"title":["Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study."],"prefix":"10.1136","volume":"55","author":[{"given":"L K","family":"Toivonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M S","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Manninen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H","family":"Frick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-2999(80)90071-0","article-title":"Effects of pirmenol HCI on electrophysiologic properties of cardiac Purkinje fibers","volume":"61","author":"Reder, R.F.; Danilo, P.; Rosen, M.R.","year":"1980","unstructured":"Reder RF, Danilo P, Rosen MR. Effects of pirmenol HCI on electrophysiologic properties of cardiac Purkinje fibers. Eur J Pharmacol 1980; 61: 321-33.","journal-title":"Eur J Pharmacol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.65.2.369","article-title":"Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics","volume":"65","author":"Hammill, S.G.; Shand, D.G.; Routledge, P.A.; Hindman, M.C.; Baker, J.T.; Pritchett, E.L.C.","year":"1982","unstructured":"Hammill SG, Shand DG, Routledge PA, Hindman MC, Baker JT, Pritchett ELC. Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics. Circulation 1982; 65: 369-74.","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0002-9149(84)90024-9","article-title":"Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study","volume":"53","author":"Anderson, J.L.; Lutz, JR, Nappi; J.M.","year":"1984","unstructured":"Anderson JL, Lutz JR, Nappi JM. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study. Am J Cardiol 1984; 53: 522-7","journal-title":"Am J Cardiol"},{"key":"ref_4","first-page":"165","article-title":"Pirmenol in termination of paroxysmal supraventicular tachycardia","volume":"17","author":"Toivonen, L.K.; Nieminen, M.S.; Manninen, V.; Frick, M.N.","year":"1985","unstructured":"Toivonen LK, Nieminen MS, Manninen V, Frick MN. Pirmenol in termination of paroxysmal supraventicular tachycardia [Abstract]. Ann Clin Res 1985; 17: 165-6.","journal-title":"Ann Clin Res"},{"key":"ref_5","article-title":"Electrophysiological and cardiovascular effects of pirmenol, a new class 1 antiarrhythmic drug","author":"Dukes, I.D.; Vaughan Williams, E.M.; Dennis, P.D.","unstructured":"Dukes ID, Vaughan Williams EM, Dennis PD. Electrophysiological and cardiovascular effects of pirmenol, a new class 1 antiarrhythmic drug. J Cardiovasc Pharmacol (in press).","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref_6","first-page":"50","article-title":"CI-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent","volume":"214","author":"Steffe, T.J.; Mertz, T.E.; Hastings, S.G.; Potoczak, R.E.; Kaplan, H.R.","year":"1980","unstructured":"Steffe TJ, Mertz TE, Hastings SG, Potoczak RE, Kaplan HR. CI-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent. J Pharmacol Exp Ther 1980; 214: 50-7.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/eurheartj\/1.5.375","article-title":"Recommendations for standardization of measurements for M-mode echocardiography","volume":"1","author":"Roelant, J.; Gibson, D.G.","year":"1980","unstructured":"Roelant J, Gibson DG. Recommendations for standardization of measurements for M-mode echocardiography. Eur Heart J 1980; 1: 375-8","journal-title":"Eur Heart J"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0378-4347(00)80174-7","article-title":"High performance liquid chromatography analysis of a new antiarrhythmic drug, pirmenol, in biological fluids","volume":"224","author":"Shand, D.G.; Verghese, C.; Barchowsky, A.; Hammill, S.C.; Pritchett, E.L.C.","year":"1981","unstructured":"Shand DG, Verghese C, Barchowsky A, Hammill SC, Pritchett ELC. High performance liquid chromatography analysis of a new antiarrhythmic drug, pirmenol, in biological fluids. J Chromatogr 1981; 224: 343-7.","journal-title":"J Chromatogr"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/hrt.44.5.589","article-title":"Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size","volume":"44","author":"Halpern, S.W.; Ellrodt, G.; Singh, B.N.; Mandel, W.J.","year":"1980","unstructured":"Halpern SW, Ellrodt G, Singh BN, Mandel WJ. Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size. Br Heart J 1980; 44: 589-95.","journal-title":"Br Heart J"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-8703(83)90692-0","article-title":"Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion","volume":"106","author":"Fenster, P.E.; Comess, K.A.; Marsh, R.; Katzenberg, C.; Hager, W.D.","year":"1983","unstructured":"Fenster PE, Comess KA, Marsh R, Katzenberg C, Hager WD. Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J 1983; 106: 501-4.","journal-title":"Am Heart J"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2125.1979.tb01023.x","article-title":"The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias","volume":"8","author":"Camm, J.; Ward, D.; Spurrell, R.A.J.","year":"1979","unstructured":"Camm J, Ward D, Spurrell RAJ. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias. Br J Clin Pharmacol 1979; 8: 441-9.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0167-5273(85)90172-X","article-title":"Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response","volume":"7","author":"Strasberg, B.; Arditti, A.; Sclarovsky, S.; Lewin, R.F.; Buimovici, B.; Agmon, J.","year":"1985","unstructured":"Strasberg B, Arditti A, Sclarovsky S, Lewin RF, Buimovici B, Agmon J. Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response. Int J Cardiol 1985; 7: 47-55.","journal-title":"Int J Cardiol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/oxfordjournals.eurheartj.a061897","article-title":"Conversion of supraventricular arrhythmias to sinus rhythm using flecainide","volume":"6","author":"Goy, J.-J.; Grbig, M.; Hurni, M.","year":"1985","unstructured":"Goy J-J, Grbig M, Hurni M, et al. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide. Eur Heart J 1985; 6: 518-24.","journal-title":"Eur Heart J"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-8703(75)90431-7","article-title":"Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram","volume":"90","author":"Heng, M.K.; Singh, B.N.; Roche, A.H.G.; Norris, R.N.; Mercer, C.J.","year":"1975","unstructured":"Heng MK, Singh BN, Roche AHG, Norris RN, Mercer CJ. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. Am Heart J 1975; 90: 487-98.","journal-title":"Am Heart J"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-94-1-1","article-title":"Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter","volume":"94","author":"Waxman, H.L.; Myerburg, R.J.; Appel, R.; Sung, R.J.","year":"1981","unstructured":"Waxman HL, Myerburg RJ, Appel R, Sung RJ. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter. Ann Intern Med 1981; 94: 1-6.","journal-title":"Ann Intern Med"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/cpt1979265578","article-title":"Verapamil in atrial fibrillation and atrial flutter","volume":"26","author":"Aronow, W.S.; Landa, D.; Placencia, G.; Wong, R.; Karlsberg, R.P.; Ferling, J.","year":"1979","unstructured":"Aronow WS, Landa D, Placencia G, Wong R, Karlsberg RP, Ferling J. Verapamil in atrial fibrillation and atrial flutter. Clin Pharmacol Ther 1979; 26: 578-83.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.CIR.53.2.273","article-title":"Relation between echocardiographically determined left atrial size and atrial fibrillation","volume":"53","author":"Henry, W.L.; Morganroth, J.; Pearlman, A.S.","year":"1976","unstructured":"Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53: 273-9.","journal-title":"Circulation"},{"key":"ref_18","first-page":"44","article-title":"Total mapping of atrial excitation during acetylcholine-induced atrial flutter and fibrillation in the isolated canine heart","author":"Allessie, M.A.; Lammers, W.; Smeets, J.; Bonke, F.; Hollen, J.","year":"1980","unstructured":"Allessie MA, Lammers W, Smeets J, Bonke F, Hollen J. Total mapping of atrial excitation during acetylcholine-induced atrial flutter and fibrillation in the isolated canine heart. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrialfibrillation. Molndal, Sweden: AB Hassle, 1980: 44-59."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.RES.25.4.439","article-title":"Influence of the direction of the atrial wave front on A-V nodal transmission in isolated hearts of rabbits","volume":"25","author":"Janse, M.J.","year":"1969","unstructured":"Janse MJ. Influence of the direction of the atrial wave front on A-V nodal transmission in isolated hearts of rabbits. Circ Res 1969; 25: 439-49.","journal-title":"Circ Res"},{"key":"ref_20","first-page":"754","article-title":"Atrioventricular nodal conduction during atrial fibrillation in rabbit heart","volume":"243","author":"Mazgalew, T.; Dreifus, L.S.; Bianchi, J.; Michelson, E.L.","year":"1982","unstructured":"Mazgalew T, Dreifus LS, Bianchi J, Michelson EL. Atrioventricular nodal conduction during atrial fibrillation in rabbit heart. Am J Physiol 1982; 243: H754-60.","journal-title":"Am J Physiol"},{"key":"ref_21","first-page":"133","article-title":"Pirmenol","volume-title":"drugs annual: cardiovascular drugs volume 1","author":"Kaplan, H.R.; Mertz, T.E.; Steffe, T.J.; Toole, J.G.","year":"1983","unstructured":"Kaplan HR, Mertz TE, Steffe TJ, Toole JG. Pirmenol. In: Scriabine A, ed. New drugs annual: cardiovascular drugs volume 1. New York: Raven Press, 1983:133-50."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/hrt.33.4.522","article-title":"Treatment and prevention of cardiac arrhythmias with propranolol and quinidine","volume":"33","author":"Stern, S.","year":"1971","unstructured":"Stern S. Treatment and prevention of cardiac arrhythmias with propranolol and quinidine. Br HeartJ 1971; 33: 522-5.","journal-title":"Br HeartJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-8703(82)90532-4","article-title":"Electrophysiologic effects of procainamide on sinus function in patients with and without sinus node disorder","volume":"103","author":"Goldberg, D.; Reiffel, J.A.; Davis, J.C.; Gang, E.; Livelli, F.; Bigger, J.T.","year":"1982","unstructured":"Goldberg D, Reiffel JA, Davis JC, Gang E, Livelli F, Bigger JT. Electrophysiologic effects of procainamide on sinus function in patients with and without sinus node disorder. Am Heart J 1982; 103: 75-9.","journal-title":"Am Heart J"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1253\/jcj.46.693","article-title":"Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction","volume":"46","author":"Tsuchioka, J.; Mitsuda, H.; Eno, S.","year":"1982","unstructured":"Tsuchioka J, Mitsuda H, Eno S, et al. Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction. Jpn Circ J 1982; 46: 693-700.","journal-title":"Jpn Circ J"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.CIR.57.3.448","article-title":"Electrophysiologic effects of lidocaine on sinus node and atrium in patients with and without sinoatrial dysfunction","volume":"57","author":"Dhingra, R.C.; Deedwania, P.C.; Cummings, J.M.; etal","year":"1978","unstructured":"Dhingra RC, Deedwania PC, Cummings JM, etal. Electrophysiologic effects of lidocaine on sinus node and atrium in patients with and without sinoatrial dysfunction. Circulation 1978; 57: 448-54.","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/clpt.1982.153","article-title":"Hemodynamic effects ofthe antiarrhythmic drug, pirmenol","volume":"32","author":"Phillips, H.R.; Stack, R.S.; Davis, D.D.","year":"1982","unstructured":"Phillips HR, Stack RS, Davis DD, et al. Hemodynamic effects ofthe antiarrhythmic drug, pirmenol. Clin Pharmacol Ther 1982; 32: 235-9.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.55.2.176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:00:29Z","timestamp":1601082029000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.55.2.176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,2,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/hrt.55.2.176","relation":{},"ISSN":["1355-6037"],"issn-type":[{"value":"1355-6037","type":"print"}],"subject":[],"published":{"date-parts":[[1986,2,1]]}}}